Victor M Elner MD PhD
Oculo-Plastic & Orbital Reconstructive Surgery
Ravitz Foundation Professor of Ophthalmology, Professor of Pathology, University of Michigan Kellogg Eye Center
Join to view full profile
1000 Wall StAnn Arbor, MI 48105
Phone+1 734-764-4190
Dr. Elner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Victor Elner is an oculoplastics specialist who sees patients at the University of Michigan Kellogg Eye Center in Ann Arbor. His clinical interests include the evaluation and treatment of eyelid and orbital tumors, thyroid (Graves') eye disease, eyelid and brow ptosis, eyelid malpositions, lacrimal system abnormalities, and comprehensive ophthalmic pathology.
In 2008, Dr. Elner was named the Ravitz Foundation Professor of Ophthalmology and Visual Sciences. He also serves as Professor of Pathology at the U-M Medical School. To make an appointment, please call Kellogg’s Eye Plastic, Orbital and Facial Cosmetic Surgery Clinic at 734-764-5106. To refer a patient, please visit www.kellogg.umich.edu/refer.
Education & Training
University of ChicagoResidency, Pathology-Anatomic and Clinical, 1982 - 1985- University of ChicagoResidency, Ophthalmology, 1979 - 1982
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1979
Certifications & Licensure
MI State Medical License 1988 - 2028
IL State Medical License 1981 - 1987
WI State Medical License 1986 - 1987
American Board of Ophthalmology Ophthalmology
American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Repeat Gene Expression Profiling, Preferentially Expressed Antigen in Melanoma Status, and Next-Generation Sequencing Testing in Uveal Melanoma Undergoing Secondary Th...Gurcan Dogukan Arslan, Mehriban Alizada, Suleyman Ciftci, Buse Guneri Beser, Satinder Pal Singh
American Journal of Ophthalmology. 2026-08-25 - Pembrolizumab, PD-1 Blocking Immune Checkpoint Inhibitor, for the Management of Periocular Sebaceous Carcinoma.Hakan Demirci, Mehriban Alizada, Satinder Pal Singh, Dogukan Gurcan Arslan, Farida Zhumageldiyeva
Ophthalmic Plastic and Reconstructive Surgery. 2026-07-24 - Combined Excisional Biopsy and Reconstruction With Eccentric Anterior Lamellar Keratoplasty in the Treatment of Corneal Limbal Dermoid.Gurcan Dogukan Arslan, Christopher Hood, Farida Zhumageldiyeva, Victor Elner, Hakan Demirci
Cornea. 2026-06-16
Press Mentions
OcuSciences Announces Publication Showing Flavoprotein Fluorescence May Detect Improvement in Metabolic Function Preceding Structural Improvement in Patients with Diabetic Macular Edema Treated with Anti-VEGFJanuary 2nd, 2019- OcuSciences Announces Publication Showing OcuMet Beacon Retinal Imager May Detect Glaucoma Earlier Than Current Standard Measures and Be Useful in Assessing Disease SeverityOctober 23rd, 2018
Grant Support
- Rpe-Mphi Binding: Ca++_&O2-_dependent AMD ResponsesNational Eye Institute2004–2008
- Retinal Cell/Leukocyte Binding Induces Cxc/Cc ChemokinesNational Eye Institute1999–2002
- Cytokine Networks Regulate RPE Leukocyte ChemotaxinsNational Eye Institute1992–1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: